Treatment Strategies for Pancreatic Ductal Adenocarcinoma: Exploring Multimodal Therapeutic Approaches

Authors: Alam M* , Abbas K and Mustafa M

DOI: 10.23880/ijbp-16000263

Volume 9, Issue 2

Abstract

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most formidable malignancies. The gloomy prognosis of PDAC is attributed to its aggressive nature, which is characterized by expeditious metastasis, treatment resistance, and lack of early detection methods. PDAC is driven by genetic alterations, including mutations in the KRAS oncogene, TP53, CDKN2A, and SMAD4

Keywords: Adenocarcinoma; PDAC; Tumor

View PDF